Note: Community Care RX's revenues are gauged from an analysis of company filings.
Community Care RX's Income Statement (based on Industry Averages)
Community Care RX P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Community Care RX is developing and marketing.
Community Care RX doesn't have any recent trademark applications, indicating Community Care RX is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
COMMUNITY CARE RX Institutional retail pharmacy services
08/28/2020
See all trademarks and details in the Full Report.
Market Share of Community Care RX's Largest Competitors
A competitive analysis shows these companies are in the same general field as Community Care RX, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Community Care RX.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Community Care RX's Fastest Growing Competitors
These companies are in the same general field as Community Care RX and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
